Get started
Author

Benjamin Kuritzky

Observed name: Kuritzky, Benjamin
Institution: TriHealth
OpenAlex ID: A5060547432
FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study
2015 · Howard Safran, Kevin P. Charpentier, et al. · American Journal of Clinical Oncology · 15
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
2014 · Jorge Castillo, Meera Iyengar, et al. · OncoTargets and Therapy · 14
PDF
Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature
2013 · Brady E. Beltrán, Benjamin Kuritzky, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13
Vertebral Compression Fractures in Patients with Chronic Lymphocytic Leukemia: Incidence and Risk Factors
2012 · Amrita Desai, Benjamin Kuritzky, et al. · Blood · 2
TriHealth Cancer Institute’s collaboration with the Tempus AI TIME program impact on clinical trial operations and enrollment.
2024 · James F. Maher, Samantha Mallahan, et al. · Journal of Clinical Oncology · 1
Abstract CT275: A phase 2, randomized, open-label study of onvansertib in combination with standard-of-care (SoC) versus SoC alone for first-line treatment of RAS-mutant metastatic colorectal cancer (mCRC)
2024 · Heinz-Josef Lenz, Benjamin Kuritzky, et al. · Cancer Research
Untreated Atherosclerotic Cardiovascular Disease Risk in Breast Cancer Survivors
2021 · Ravleen Grewal, Amie Jackson, et al. · Journal of the American College of Cardiology
How high a bar to change neoadjuvant therapy for triple-negative breast cancer?
2015 · Benjamin Kuritzky, William M Sikov · Journal of Comparative Effectiveness Research
FOLFOX + Nab-paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Study
2014 · Howard Safran, Kalyan Mantripragada, et al. · Europe PMC (PubMed Central)
Works count: 11
Citation count: 46
H-index: 3
I10-index: 3
Year
Topic
Type